|
|
Article: One millionth Taxus Express Coronary Stent system implanted.(OBSERVATIONS)
- Article from:
- Advanced Materials & Processes
- Article date:
- April 1, 2005
CopyrightCOPYRIGHT 2005 ASM International. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Boston Scientific Corporation, Natick, Mass., has announced the implantation of its millionth Taxus Express paclitaxel-eluting coronary stent system, marking a major milestone for the company and for the treatment of coronary artery disease.
"The implantation of our millionth Taxus stent system is a significant symbolic achievement for Boston Scientific," says Jim Tobin, President and Chief Executive Officer of Boston Scientific. "We are gratified that the Taxus system has become the preferred treatment option for clinicians, but more important, we are pleased that so many patients have benefited from this innovative, life-enhancing technology." ...